Some areas of AAO.org are temporarily unavailable. We apologize for the inconvenience and are working to restore access.

  • Cataract/Anterior Segment

    This randomized, placebo-controlled study finds that patients with cornea guttata who used dorzolamide for four weeks experienced a statistically significantly increase in central cornea thickness. The authors recommend physicians closely monitor patients with corneal endothelial problems taking dorzolamide.  Archives of Ophthalmology, October 2007

    View Abstract